EAM Investors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$1,773,164
-9.7%
22,545
-15.0%
0.37%
-14.1%
Q3 2022$1,964,000
+34.2%
26,532
+18.2%
0.43%
+19.6%
Q2 2022$1,463,000
-33.2%
22,450
+29.3%
0.36%
-38.3%
Q3 2019$2,191,000
+3.4%
17,369
-1.3%
0.58%
+11.8%
Q2 2019$2,118,000
+0.8%
17,596
-16.2%
0.52%
-9.3%
Q4 2018$2,102,000
-48.4%
21,006
-40.9%
0.57%
-5.6%
Q3 2018$4,071,000
+18.8%
35,527
-7.1%
0.60%
+11.8%
Q2 2018$3,428,000
+11.4%
38,228
-9.2%
0.54%
+5.7%
Q1 2018$3,078,00042,0790.51%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders